360 High-Risk Vulnerability Immunization Tool V2.0 vs Karamba VMS: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0

Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.

Karamba VMS

Product security teams at mid-market and enterprise companies shipping automotive or medical devices should start here; Karamba VMS maps vulnerabilities directly to blast radius across your product lines and firmware versions, which matters when a CVE in one component can affect regulatory compliance across multiple SKUs. The tool ingests from seven sources (NVD, TARA reports, binary scanning, bug bounty feeds) and generates UNECE R155 and ISO 21434 compliance reports without manual translation, addressing the specific reporting burden those teams face. Skip this if your organization is still on-premises only or needs a general-purpose VM platform for IT infrastructure; Karamba is product-centric and cloud-delivered.